Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2012
08/08/2012CN101374529B Method of stabilizing s-adenosyl-l-methionine and stabilized composition
08/08/2012CN101361865B Medicinal preparation
08/08/2012CN101190306B Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof
08/08/2012CN101148642B Probiotic/non-probiotic combinations
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/08/2012CN101074202B Production of injecting reductive glutathione
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236804 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012CA2601904C Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods
08/07/2012CA2553827C New combinations of an anti emetic agent and an enkephalinase inhibitor
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2429216C Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors
08/07/2012CA2217251C Enhancing and stabilizing agent of the activity of bifidus factor
08/02/2012WO2012102366A1 Method for producing novel piperazine compound
08/02/2012WO2012102277A1 Gastrin production inhibitor and food composition comprising same
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012100748A1 Glp-1 receptor agonist for treating pain
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012068209A3 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
08/02/2012WO2012067481A3 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
08/02/2012WO2012050922A3 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
08/02/2012WO2011113802A3 Imidazopyridine and purine compounds, compositions and methods of use
08/02/2012US20120196936 Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196920 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases
08/02/2012US20120196919 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196887 Methods and compositions for improved rifamycin therapies
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196878 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196819 Animal treatments
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196811 Veterinary pharmaceutical composition and method (alternatives) for the prophylaxis and treatment of diseases of the gastrointestinal tract and intoxications of diverse etiology in animals
08/02/2012US20120196797 Methods and Compositions for the Treatment of Gastrointestinal Disorders
08/02/2012US20120196790 Cyclic depsipeptides
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196749 Cyclosporin Derivatives
08/02/2012US20120195986 Preventing or treating periodontal diseases by herbal extract
08/02/2012US20120195981 Micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
08/02/2012US20120195980 Method, Composition and Package for Bowel Cleansing
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195975 Immune stimulatory infant nutrition
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195930 Novel pyridine derivatives
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195875 Detection of immune modulation resulting from reduced protein phosphatase 2a activity
08/02/2012US20120195868 Nutritional compositions comprising fiber and probiotics
08/02/2012US20120195859 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481417A1 Lactase preparation
08/01/2012EP2481413A1 Veterinary pharmaceutical composition and method (alternatives) for the prophylaxis and treatment of diseases of the gastrointestinal tract and intoxications of diverse etiology in animals
08/01/2012EP2481403A1 Pharmaceutical combination of otilonium and trimebutine
08/01/2012EP2480255A1 Therapy for enteric infections
08/01/2012EP2480232A1 Disubstituted ]4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
08/01/2012EP2480226A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
08/01/2012EP2480098A2 Nutritional compositions including theanine and exogenous nucleotides
08/01/2012EP2480086A1 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
08/01/2012EP2159224B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
08/01/2012EP2149382B1 Dentinogenesis inducer and dentinogenesis pulp-capping material
08/01/2012EP2127646B1 Agent for relief or prevention of xerostomia
08/01/2012EP1915994B1 Cyclic amine derivatives in combination with ppar regulators
08/01/2012EP1669080B1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1303192B1 Dietary lipids for improving skin and coat of pets
08/01/2012CN1993333B Triazole derivative
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102625699A Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
08/01/2012CN102621243A Fingerprint spectrum of henbane medicinal material and method for controlling quality of henbane medicinal material
08/01/2012CN102618425A Acer truncatum health-care wine and preparation method thereof
08/01/2012CN102618423A Healthcare wine containing queen bees
08/01/2012CN102618413A Production method of traditional Chinese medicine alcoholic drink
08/01/2012CN102617735A Antibodies against human IL17 and uses thereof
08/01/2012CN102617734A Antibody Dab-2 against FGF-2 and application thereof
08/01/2012CN102617727A Thymalfasin compound and novel preparation method thereof
08/01/2012CN102617676A Zidovudine quinoline conjugated compound, preparation method thereof and application for liver cancer resistance
08/01/2012CN102617596A Dimeric sesquiterpene compound Hippolide I, its preparation method and its purpose
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617571A Novel pyridazine compound and use thereof
08/01/2012CN102617555A Preparation method of lansoprazole
08/01/2012CN102617536A Isoflavone compound, its preparation method, and its application in preparation of antiviral or antitumor drugs
08/01/2012CN102617533A Compound separated from red yeast rice, its preparation method and application
08/01/2012CN102614528A Polyconjugates for in vivo delivery of polynucleotides
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
1 ... 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 ... 1258